Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study

Atherosclerosis

Volumn 255, Issue , 2016, Pages 73-79

  Nakanishi, Rine ^a   Ceponiene, Indre ^a   Osawa, Kazuhiro ^a   Luo, Yanting ^a   Kanisawa, Mitsuru ^a   Megowan, Nichelle ^a   Nezarat, Negin ^a   Rahmani, Sina ^a   Broersen, Alexander ^b   Kitslaar, Pieter H ^b,c   Dailing, Christopher ^a   Budoff, Matthew J ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Medis Medical Imaging Systems bv   (Netherlands)

Author keywords

Coronary computed tomography angiography; Diabetes; Plaque progression

Indexed keywords

CALCIUM; LIPID;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; AUTOMATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY; CORONARY ARTERY CALCIUM SCORE; CORONARY STENTING; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPENSITY SCORE; QUANTITATIVE ANALYSIS; RISK FACTOR; SOFTWARE; BLOOD VESSEL CALCIFICATION; CALIFORNIA; CHEMISTRY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED DIAGNOSIS; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DIAGNOSTIC IMAGING; FIBROSIS; METABOLISM; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; STATISTICAL MODEL; TIME FACTOR;

AGED; AUTOMATION; CALIFORNIA; COMPUTED TOMOGRAPHY ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY VESSELS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; LINEAR MODELS; LIPIDS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; PREDICTIVE VALUE OF TESTS; PROPENSITY SCORE; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; RISK FACTORS; SOFTWARE; TIME FACTORS; VASCULAR CALCIFICATION;

EID: 84994614298     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.11.004     Document Type: Article

References (46)

1. [1] Increasing prevalence of diagnosed diabetes–United States and Puerto Rico, 1995-2010. MMWR Morb. Mortal. Wkly. Rep. 61 (2012), 918–921.
2. [2] Tancredi, M., Rosengren, A., Svensson, A.M., Kosiborod, M., Pivodic, A., et al. Excess mortality among persons with type 2 diabetes. N. Engl. J. Med. 373 (2015), 1720–1732.
3. [3] Stone, N.J., Robinson, J., Lichtenstein, A.H., Bairey Merz, C.N., Lloyd-Jones, D.M., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology/American heart association task force on practice guidelines. J. Am. Coll. Cardiol. 63:25 (2014), 2889–2934.
4. [4] Smith, S.C. Jr., Allen, J., Blair, S.N., Bonow, R.O., Brass, L.M., et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J. Am. Coll. Cardiol. 47 (2006), 2130–2139.
5. [5] Hendel, R.C., Berman, D.S., Di Carli, M.F., Heidenreich, P.A., Henkin, R.E., et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American college of cardiology foundation appropriate use criteria task force, the American society of nuclear cardiology, the American college of radiology, the American heart association, the American society of echocardiography, the society of cardiovascular computed tomography, the society for cardiovascular magnetic resonance, and the society of nuclear medicine. J. Am. Coll. Cardiol. 53 (2009), 2201–2229.
6. [6] Wolk, M.J., Bailey, S.R., Doherty, J.U., Douglas, P.S., Hendel, R.C., et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American college of cardiology foundation appropriate use criteria task force, American heart association, American society of echocardiography, American society of nuclear cardiology, heart failure society of America, heart rhythm society, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, society for cardiovascular magnetic resonance, and society of thoracic surgeons. J. Am. Coll. Cardiol. 63 (2014), 380–406.
7. [7] Cortigiani, L., Bigi, R., Sicari, R., Landi, P., Bovenzi, F., et al. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. J. Am. Coll. Cardiol. 47 (2006), 605–610.
8. [8] Acampa, W., Petretta, M., Cuocolo, R., Daniele, S., Cantoni, V., et al. Warranty period of normal stress myocardial perfusion imaging in diabetic patients: a propensity score analysis. J. Nucl. Cardiol. 21 (2014), 50–56.
9. [9] Acampa, W., Cantoni, V., Green, R., Maio, F., Daniele, S., et al. Prognostic value of normal stress myocardial perfusion imaging in diabetic patients: a meta-analysis. J. Nucl. Cardiol. 21 (2014), 893–902 quiz 890-2, 903-5.
10. [10] Valenti, V., Hartaigh, B.O., Cho, I., Schulman-Marcus, J., Gransar, H., et al. Absence of coronary artery calcium identifies asymptomatic diabetic individuals at low near-term but not long-term risk of mortality: a 15-Year follow-up study of 9715 patients. Circ. Cardiovasc Imaging., 9, 2016, e003528.
11. [11] Nakanishi, R., Li, D., Blaha, M.J., Whelton, S.P., Darabian, S., et al. All-cause mortality by age and gender based on coronary artery calcium scores. Eur. Heart J. Cardiovasc Imaging., 2015 [Epub ahead of print].
12. [12] Valenti, V., Ó Hartaigh, B., Heo, R., Cho, I., Schulman-Marcus, J., et al. A 15-Year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9,715 individuals. JACC Cardiovasc Imaging. 8 (2015), 900–909.
13. [13] Zellweger, M.J., Maraun, M., Osterhues, H.H., Keller, U., Muller-Brand, J., et al. Progression to overt or silent CAD in asymptomatic patients with diabetes mellitus at high coronary risk: main findings of the prospective multicenter BARDOT trial with a pilot randomized treatment substudy. JACC Cardiovasc Imaging. 7 (2014), 1001–1010.
14. [14] Rana, J.S., Dunning, A., Achenbach, S., Al-Mallah, M., Budoff, M.J., et al. Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (COronary CT Angiography EvaluatioN for Clinical Outcomes): an InteRnational Multicenter Registry. Diabetes Care 35 (2012), 1787–1794.
15. [15] Nakanishi, R., Berman, D.S., Budoff, M.J., Gransar, H., Achenbach, S., et al. Current but not past smoking increases the risk of cardiac events: insights from coronary computed tomographic angiography. Eur. Heart J. 36 (2015), 1031–1040.
16. [16] Min, J.K., Labounty, T.M., Gomez, M.J., Achenbach, S., Al-Mallah, M., et al. Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals. Atherosclerosis 232 (2014), 298–304.
17. [17] Motoyama, S., Ito, H., Sarai, M., Kondo, T., Kawai, H., et al. Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J. Am. Coll. Cardiol. 66 (2015), 337–346.
18. [18] Nasir, K., Rubin, J., Blaha, M.J., Shaw, L.J., Blankstein, R., et al. Interplay of coronary artery calcification and traditional risk factors for the prediction of all-cause mortality in asymptomatic individuals. Circ. Cardiovasc Imaging. 5 (2012), 467–473.
19. [19] Agatston, A.S., Janowitz, W.R., Hildner, F.J., Zusmer, N.R., Viamonte, M., et al. Quantification of coronary artery calcium using ultrafast computed tomography. J. Am. Coll. Cardiol. 15 (1990), 827–832.
20. [20] Leipsic, J., Abbara, S., Achenbach, S., Cury, R., Earls, J.P., et al. SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J. Cardiovasc Comput. Tomogr. 8 (2014), 342–358.
21. [21] Papadopoulou, S.L., Neefjes, L.A., Garcia-Garcia, H.M., Flu, W.J., Rossi, A., et al. Natural history of coronary atherosclerosis by multislice computed tomography. JACC Cardiovasc Imaging. 5 (2012), S28–S37.
22. [22] Fahmy, M., Nakanishi, R., Matsumoto, S., Alani, A., Abraham, J., et al. Inter-observer reproducibility in a novel semi-automated coronary plaque quantification software [abstract]. J. Cardiovasc Comput. Tomogr., 2014 (Suppl).
23. [23] de Graaf, M.A., Broersen, A., Kitslaar, P.H., Roos, C.J., Dijkstra, J., et al. Automatic quantification and characterization of coronary atherosclerosis with computed tomography coronary angiography: cross-correlation with intravascular ultrasound virtual histology. Int. J. Cardiovasc Imaging. 29 (2013), 1177–1190.
24. [24] Rosenbaum, P.R., Attributing effects to treatment in matched observational studies. J. Am. Stat. Assoc. 97:457 (2002), 183–192.
25. [25] Raggi, P., Cooil, B., Ratti, C., Callister, T.Q., Budoff, M., Progression of coronary artery calcium and occurrence of myocardial infarction in patients with and without diabetes mellitus. Hypertension 46 (2005), 238–243.
26. [26] Kiramijyan, S., Ahmadi, N., Isma'eel, H., Flores, F., Shaw, L.J., et al. Impact of coronary artery calcium progression and statin therapy on clinical outcome in subjects with and without diabetes mellitus. Am. J. Cardiol. 111 (2013), 356–361.
27. [27] Nicholls, S.J., Tuzcu, E.M., Kalidindi, S., Wolski, K., Moon, K.W., et al. Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials. J. Am. Coll. Cardiol. 52 (2008), 255–262.
28. [28] Kristensen, T.S., Kofoed, K.F., Kuhl, J.T., Nielsen, W.B., Nielsen, M.B., et al. Prognostic implications of nonobstructive coronary plaques in patients with non-ST-segment elevation myocardial infarction: a multidetector computed tomography study. J. Am. Coll. Cardiol. 58 (2011), 502–509.
29. [29] Burke, A.P., Kolodgie, F.D., Zieske, A., Fowler, D.R., Weber, D.K., et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler. Thromb. Vasc. Biol. 24 (2004), 1266–1271.
30. [30] Virmani, R., Burke, A.P., Kolodgie, F., Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can. J. Cardiol., 22(Suppl B:81B-84B), 2006.
31. [31] Inaba, S., Okayama, H., Funada, J., Higashi, H., Saito, M., et al. Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis. Eur. Heart J. Cardiovasc Imaging. 13 (2012), 717–723.
32. [32] Nicholls, S.J., Tuzcu, E.M., Crowe, T., Sipahi, I., Schoenhagen, P., et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J. Am. Coll. Cardiol. 47 (2006), 1967–1975.
33. [33] Bayturan, O., Tuzcu, E.M., Uno, K., Lavoie, A.J., Hu, T., et al. Comparison of rates of progression of coronary atherosclerosis in patients with diabetes mellitus versus those with the metabolic syndrome. Am. J. Cardiol. 105 (2010), 1735–1739.
34. [34] Niccoli, G., Giubilato, S., Di Vito, L., Leo, A., Cosentino, N., et al. Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox. Eur. Heart J. 34 (2013), 729–741.
35. [35] Yonetsu, T., Kato, K., Uemura, S., Kim, B.K., Jang, Y., et al. Features of coronary plaque in patients with metabolic syndrome and diabetes mellitus assessed by 3-vessel optical coherence tomography. Circ. Cardiovasc Imaging. 6 (2013), 665–673.
36. [36] Rodriguez, K., Kwan, A.C., Lai, S., Lima, J.A., Vigneault, D., et al. Coronary plaque burden at coronary CT angiography in asymptomatic men and women. Radiology 277 (2015), 73–80.
37. [37] Min, J.K., Lin, F.Y., Gidseg, D.S., Weinsaft, J.W., Berman, D.S., et al. Determinants of coronary calcium conversion among patients with a normal coronary calcium scan: what is the “warranty period” for remaining normal?. J. Am. Coll. Cardiol. 55 (2010), 1110–1117.
38. [38] Budoff, M.J., Hokanson, J.E., Nasir, K., Shaw, L.J., Kinney, G.L., et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging. 3 (2010), 1229–1236.
39. [39] Anand, D.V., Lim, E., Darko, D., Bassett, P., Hopkins, D., et al. Determinants of progression of coronary artery calcification in type 2 diabetes role of glycemic control and inflammatory/vascular calcification markers. J. Am. Coll. Cardiol. 50 (2007), 2218–2225.
40. [40] Joshi, F.R., Rajani, N.K., Abt, M., Woodward, M., Bucerius, J., et al. Does vascular calcification accelerate Inflammation?: a substudy of the dal-PLAQUE trial. J. Am. Coll. Cardiol. 67 (2016), 69–78.
41. [41] Kubo, T., Maehara, A., Mintz, G.S., Doi, H., Tsujita, K., et al. The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J. Am. Coll. Cardiol. 55 (2010), 1590–1597.
42. [42] Puri, R., Nissen, S.E., Ballantyne, C.M., Barter, P.J., Chapman, M.J., et al. Factors underlying regression of coronary atheroma with potent statin therapy. Eur. Heart J. 34 (2013), 1818–1825.
43. [43] Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur. Heart J. 33 (2012), 1635–1701.
44. [44] Inoue, K., Motoyama, S., Sarai, M., Sato, T., Harigaya, H., et al. Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging. 3 (2010), 691–698.
45. [45] Zeb, I., Li, D., Nasir, K., Malpeso, J., Batool, A., et al. Effect of statin treatment on coronary plaque progression - a serial coronary CT angiography study. Atherosclerosis 231 (2013), 198–204.
46. [46] Muhlestein, J.B., Lappe, D.L., Lima, J.A., Rosen, B.D., May, H.T., et al. Effect of screening for coronary artery disease using CT angiography on mortality and cardiac events in high-risk patients with diabetes: the FACTOR-64 randomized clinical trial. JAMA 312 (2014), 2234–2243.